ADGRG3
Adhesion G protein-coupled receptor G3
Also known as: AGRG3_HUMAN, GPR97, Pb99, PGR26
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86Y34
- Gene
- ADGRG3
- Ensembl
- ENSG00000182885
- Chromosome
- 16
- Canonical length
- 549 aa
- Protein class
- G-protein coupled receptors, Plasma proteins, Predicted membrane proteins
OverviewNCBI Gene
Predicted to enable G protein-coupled receptor activity. Involved in G protein-coupled receptor signaling pathway and regulation of cell migration. Located in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
549 residues, UniProt reviewed canonical sequence.
>Q86Y34|ADGRG3
1 MATPRGLGAL LLLLLLPTSG QEKPTEGPRN TCLGSNNMYD IFNLNDKALC FTKCRQSGSD
61 SCNVENLQRY WLNYEAHLMK EGLTQKVNTP FLKALVQNLS TNTAEDFYFS LEPSQVPRQV
121 MKDEDKPPDR VRLPKSLFRS LPGNRSVVRL AVTILDIGPG TLFKGPRLGL GDGSGVLNNR
181 LVGLSVGQMH VTKLAEPLEI VFSHQRPPPN MTLTCVFWDV TKGTTGDWSS EGCSTEVRPE
241 GTVCCCDHLT FFALLLRPTL DQSTVHILTR ISQAGCGVSM IFLAFTIILY AFLRLSRERF
301 KSEDAPKIHV ALGGSLFLLN LAFLVNVGSG SKGSDAACWA RGAVFHYFLL CAFTWMGLEA
361 FHLYLLAVRV FNTYFGHYFL KLSLVGWGLP ALMVIGTGSA NSYGLYTIRD RENRTSLELC
421 WFREGTTMYA LYITVHGYFL ITFLFGMVVL ALVVWKIFTL SRATAVKERG KNRKKVLTLL
481 GLSSLVGVTW GLAIFTPLGL STVYIFALFN SLQGVFICCW FTILYLPSQS TTVSSSTARL
541 DQAHSASQELocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADGRG3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 139 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 139 nTPM
- spleen: 35 nTPM
- lung: 14 nTPM
- appendix: 14 nTPM
- adipose tissue: 7.9 nTPM
- thyroid gland: 3.7 nTPM
Single-cell type
- neutrophils: 1,722 nCPM
- neutrophil progenitors: 444 nCPM
- nk-cells: 64 nCPM
- lymphatic endothelial cells: 56 nCPM
- epididymal basal cells: 13 nCPM
- platelets: 11 nCPM
Immune cell
- neutrophil: 170 nTPM
- eosinophil: 143 nTPM
- basophil: 76 nTPM
- NK-cell: 37 nTPM
- total PBMC: 0.9 nTPM
- non-classical monocyte: 0.1 nTPM
Brain region
- cerebral cortex: 23 nTPM
- pons: 4.2 nTPM
- thalamus: 1 nTPM
- choroid plexus: 0.6 nTPM
- basal ganglia: 0.5 nTPM
- medulla oblongata: 0.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.24
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway
- B cell differentiation
- cell surface receptor signaling pathway
- G protein-coupled receptor signaling pathway
- negative regulation of CREB transcription factor activity
- negative regulation of non-canonical NF-kappaB signal transduction
- regulation of cell migration
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ADGRG3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADGRG3 as an antibody target. Whether an autoantibody or antibody against ADGRG3 could matter depends on whether native ADGRG3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADGRG3 is annotated at the cell surface, where native ADGRG3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ADGRG3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...